Literature DB >> 6831631

Radioimmunoassay for methotrexate using hydroxyethylmethacrylate hydrogel.

K J Tracey, R Mutkoski, J A Lopez, W Franzblau, C Franzblau.   

Abstract

A sensitive, rapid method for the measurement of methotrexate in biologic fluids has been developed using a solid-phase radioimmunoassay (RIA). Hydroxyethylmethacrylate monomer was polymerized in the presence of rabbit antimethotrexate antisera and the resultant gels lyophilized, ground to a fine powder, and aliquoted into 3-ml syringes fitted with a fritted filter disc. Control gels without incorporated antibodies did not bind radiolabeled methotrexate, whereas a dose-response curve expressing percent bound methotrexate against antiserum concentration could be readily constructed for appropriate gels. Drug concentrations of less than 1 ng/ml can be measured. The fate of a bolus IV injection of methotrexate (100 mg) into an adult female baboon was evaluated by the HEMA-RIA system and compared with a previously published enzyme assay for the drug. These studies describe a stable and efficient system for rapid separation of bound antigen by simple filtration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831631     DOI: 10.1007/bf00446217

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  New approaches to cancer chemotherapy with methotrexate.

Authors:  E Frei; N Jaffe; M H Tattersall; S Pitman; L Parker
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

2.  "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.

Authors:  J R Bertino
Journal:  Semin Oncol       Date:  1977-06       Impact factor: 4.929

Review 3.  Studies with high-dose methotrexate--historical background.

Authors:  A Goldin
Journal:  Cancer Treat Rep       Date:  1978-02

4.  Improved therapeutic index of methotrexate with "leucovorin rescue".

Authors:  M Levitt; M B Mosher; R C DeConti; L R Farber; R T Skeel; J C Marsh; M S Mitchell; R J Papac; E D Thomas; J R Bertino
Journal:  Cancer Res       Date:  1973-07       Impact factor: 12.701

5.  Automation and simplification of radioimmunoassay by gel entrapment of antibody.

Authors:  S J Updike
Journal:  Antibiot Chemother (1971)       Date:  1979

6.  Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern.

Authors:  J H Goldie; L A Price; K R Harrap
Journal:  Eur J Cancer       Date:  1972-08       Impact factor: 9.162

7.  Clinical pharmacology of methotrexate.

Authors:  B A Chabner; R C Donehower; R L Schilsky
Journal:  Cancer Treat Rep       Date:  1981

8.  Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.

Authors:  R G Buice; W E Evans; J Karas; C A Nicholas; P Sidhu; A B Straughn; M C Meyer; W R Crom
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

9.  Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.

Authors:  W H Isacoff; F Eilber; H Tabbarah; P Klein; M Dollinger; S Lemkin; P Sheehy; L Cone; B Rosenbloom; L Sieger; J B Block
Journal:  Cancer Treat Rep       Date:  1978-09

10.  Techniques for the measurement of methotrexate in biological samples.

Authors:  G W Aherne; M Quinton
Journal:  Cancer Treat Rep       Date:  1981
View more
  1 in total

Review 1.  New Horizons in Hydrogels for Methotrexate Delivery.

Authors:  Ali Dehshahri; Anuj Kumar; Vijay Sagar Madamsetty; Ilona Uzieliene; Shima Tavakol; Fereshteh Azedi; Hojjat Samareh Fekri; Ali Zarrabi; Reza Mohammadinejad; Vijay Kumar Thakur
Journal:  Gels       Date:  2020-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.